Todd Harris Tyra Biosciences, Inc. (TYRA) insider trading activity

Todd Harris is President and CEO of Tyra Biosciences, Inc.. Currently has a direct ownership of 1.36 Million shares of TYRA, which is worth approximately $19 Million. The most recent transaction as insider was on Oct 21, 2024, when has been sold 19,084 shares (Common Stock) at a price of $27.74 per share, resulting in proceeds of $529,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.36M

8.97% 3M change

15.4% 12M change

Total Value Held $19 Million

Todd Harris Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 21 2024	SELL Open market or private sale	$529,390 $27.74 p/Share	19,084 Reduced 1.39%	1,355,927 Common Stock
Oct 18 2024	SELL Open market or private sale	$1,178,608 $27.01 p/Share	43,636 Reduced 3.08%	1,375,011 Common Stock
Oct 17 2024	SELL Open market or private sale	$401,937 $26.11 p/Share	15,394 Reduced 1.07%	1,418,647 Common Stock
Oct 16 2024	SELL Open market or private sale	$870,383 $26.14 p/Share	33,297 Reduced 2.27%	1,434,041 Common Stock
Oct 15 2024	SELL Open market or private sale	$243,950 $24.31 p/Share	10,035 Reduced 0.68%	1,467,338 Common Stock
Sep 30 2024	SELL Open market or private sale	$12,000 $24.0 p/Share	500 Reduced 0.03%	1,477,373 Common Stock
Sep 25 2024	SELL Open market or private sale	$14,406 $24.01 p/Share	600 Reduced 0.04%	1,477,873 Common Stock
Sep 24 2024	SELL Open market or private sale	$25,341 $24.02 p/Share	1,055 Reduced 0.07%	1,478,473 Common Stock
Sep 23 2024	SELL Open market or private sale	$243,519 $24.13 p/Share	10,092 Reduced 0.68%	1,479,528 Common Stock
Sep 20 2024	SELL Open market or private sale	$171,966 $24.19 p/Share	7,109 Reduced 0.47%	1,489,620 Common Stock
Sep 19 2024	SELL Open market or private sale	$140,740 $24.7 p/Share	5,698 Reduced 0.38%	1,496,729 Common Stock
Sep 18 2024	SELL Open market or private sale	$84,000 $24.0 p/Share	3,500 Reduced 0.23%	1,502,427 Common Stock
Sep 13 2024	BUY Grant, award, or other acquisition	$8,883 $6.58 p/Share	1,350 Added 0.09%	1,505,927 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	$12,370 $6.58 p/Share	1,880 Added 0.12%	1,504,577 Common Stock
Feb 05 2024	SELL Open market or private sale	$234,474 $16.97 p/Share	13,817 Reduced 0.91%	1,502,697 Common Stock
Feb 02 2024	SELL Open market or private sale	$1,443,565 $16.75 p/Share	86,183 Reduced 5.38%	1,516,514 Common Stock
Sep 15 2023	BUY Grant, award, or other acquisition	$9,350 $6.58 p/Share	1,421 Added 0.09%	1,602,697 Common Stock
Jun 23 2023	SELL Open market or private sale	$355,210 $17.15 p/Share	20,712 Reduced 1.28%	1,601,276 Common Stock
Jun 22 2023	SELL Open market or private sale	$59,752 $17.18 p/Share	3,478 Reduced 0.21%	1,621,988 Common Stock
Jun 21 2023	SELL Open market or private sale	$342,569 $17.34 p/Share	19,756 Reduced 1.2%	1,625,466 Common Stock
Jun 20 2023	SELL Open market or private sale	$21,489 $16.53 p/Share	1,300 Reduced 0.08%	1,645,222 Common Stock
Jun 16 2023	SELL Open market or private sale	$949,981 $17.35 p/Share	54,754 Reduced 3.22%	1,646,522 Common Stock
Jun 15 2023	SELL Open market or private sale	$206,028 $16.13 p/Share	12,773 Reduced 0.75%	1,701,276 Common Stock
Jun 15 2023	BUY Exercise of conversion of derivative security	$28,739 $2.25 p/Share	12,773 Added 0.74%	1,714,049 Common Stock
Jun 13 2023	SELL Open market or private sale	$126,832 $16.0 p/Share	7,927 Reduced 0.46%	1,701,276 Common Stock

Todd Harris

President and CEO

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TYRA shares.

Notify only if

Value

Insider Trading

Get notified when an Tyra Biosciences, Inc. insider buys or sells TYRA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tyra Biosciences, Inc.

Track Activities on TYRA

Account